Axon Enterprise, Inc $AXON Shares Sold by Calamos Advisors LLC

Calamos Advisors LLC decreased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 56.5% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 3,806 shares of the biotechnology company’s stock after selling 4,944 shares during the period. Calamos Advisors LLC’s holdings in Axon Enterprise were worth $1,616,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the stock. Creative Financial Designs Inc. ADV purchased a new stake in Axon Enterprise in the fourth quarter valued at $28,000. Sound Income Strategies LLC grew its holdings in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth about $30,000. AlphaCentric Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at about $34,000. Finally, Lodestone Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter valued at about $35,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Down 1.1%

Shares of NASDAQ:AXON opened at $541.12 on Thursday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The company has a market cap of $43.61 billion, a price-to-earnings ratio of 217.32, a PEG ratio of 11.17 and a beta of 1.38. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The firm’s 50-day simple moving average is $467.24 and its 200-day simple moving average is $481.98.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. The company had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.90 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s quarterly revenue was up 33.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.47 EPS. As a group, equities research analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research reports. Citizens Jmp restated a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a research note on Thursday, June 25th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a research note on Thursday, May 7th. Barclays decreased their price objective on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating for the company in a report on Friday, May 8th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Finally, Piper Sandler upped their price target on shares of Axon Enterprise from $674.00 to $724.00 and gave the company an “overweight” rating in a research report on Monday. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $725.25.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Elizabeth Reid Coughlin sold 1,554 shares of the stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the transaction, the insider owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $488.45, for a total value of $6,349,850.00. Following the completion of the sale, the president directly owned 169,125 shares of the company’s stock, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 58,989 shares of company stock valued at $30,527,983. 4.20% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.